Drug
Anakinra Plus Osoc
Anakinra Plus Osoc: highest development phase Phase 3, developed by Swedish Orphan Biovitrum. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| Anakinra plus oSOC NCT04364009 | Phase 3 | COVID-19 Infection |
Latest
No recent events.
Follow Anakinra Plus Osoc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.